Artículos de revistas sobre el tema "BRCA genes"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "BRCA genes".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Zhang, Yinuo. "BRCA1, BRCA2 and primary ovarian insufficiency". E3S Web of Conferences 165 (2020): 05009. http://dx.doi.org/10.1051/e3sconf/202016505009.
Texto completoMcNevin, Ciara S., Karen Cadoo, Anne-Marie Baird, Pierre Murchan, Orla Sheils, Ray McDermott y Stephen Finn. "Pathogenic BRCA Variants as Biomarkers for Risk in Prostate Cancer". Cancers 13, n.º 22 (14 de noviembre de 2021): 5697. http://dx.doi.org/10.3390/cancers13225697.
Texto completoSchwartz, Zachary Phillip, Mae Zakhour, Andrew John Li, Christine S. Walsh, Bj Rimel, Monica Alvarado, Scott E. Lentz y Ilana Cass. "Comparison of risk-reducing surgery in women with BRCA and non-BRCA ovarian cancer susceptibility genes." Journal of Clinical Oncology 37, n.º 15_suppl (20 de mayo de 2019): 1547. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.1547.
Texto completoSahnane, Nora, Ileana Carnevali, Giorgio Formenti, Jvan Casarin, Sofia Facchi, Raffaella Bombelli, Eleonora Di Lauro et al. "BRCA Methylation Testing Identifies a Subset of Ovarian Carcinomas without Germline Variants That Can Benefit from PARP Inhibitor". International Journal of Molecular Sciences 21, n.º 24 (19 de diciembre de 2020): 9708. http://dx.doi.org/10.3390/ijms21249708.
Texto completoIncorvaia, Lorena, Chiara Brando, Alessandro Perez, Marco Bono, Daniela Cancelliere, Alessia Pivetti, Nadia Barraco et al. "Real life use of biomarkers of homologous recombination deficiency (HRD) status beyond BRCA to predict the effectiveness of PARP inhibitors in ovarian cancer patients." Journal of Clinical Oncology 41, n.º 16_suppl (1 de junio de 2023): 10592. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.10592.
Texto completoЖурман, В. Н., Н. Г. Плехова y М. Л. Филипенко. "Mutational Status of BRCA Genes in Ovarian Cancer". Евразийский онкологический журнал, n.º 2 (16 de agosto de 2022): 118–25. http://dx.doi.org/10.34883/pi.2022.10.2.016.
Texto completoMcNevin, Ciara S., Karen Cadoo, Anne-Marie Baird, Stephen P. Finn y Ray McDermott. "PARP Inhibitors in Advanced Prostate Cancer in Tumors with DNA Damage Signatures". Cancers 14, n.º 19 (29 de septiembre de 2022): 4751. http://dx.doi.org/10.3390/cancers14194751.
Texto completoMeireles, Pedro Antunes, Catarina Bexiga, Sofia Fragoso, Sidónia Santos, Teresa Duarte y Fátima Vaz. "Abstract PO3-08-03: Comparing prognosis for BRCA1, BRCA2 and non-BRCA breast cancer". Cancer Research 84, n.º 9_Supplement (2 de mayo de 2024): PO3–08–03—PO3–08–03. http://dx.doi.org/10.1158/1538-7445.sabcs23-po3-08-03.
Texto completoBrankovic-Magic, Mirjana, Jelena Dobricic, Radmila Jankovic, Irene Konstantopoulou, Drakoulis Yannoukakos y Sinisa Radulovic. "Identifying and testing for hereditary susceptibility to breast/ovarian cancer in Serbia: Where are we now?" Archive of Oncology 14, n.º 3-4 (2006): 131–35. http://dx.doi.org/10.2298/aoo0604131b.
Texto completoFoglietta, Jennifer, Vienna Ludovini, Fortunato Bianconi, Lorenza Pistola, Maria Sole Reda, Antonella Al-Refaie, Francesca Romana Tofanetti et al. "Prevalence and Spectrum of BRCA Germline Variants in Central Italian High Risk or Familial Breast/Ovarian Cancer Patients: A Monocentric Study". Genes 11, n.º 8 (12 de agosto de 2020): 925. http://dx.doi.org/10.3390/genes11080925.
Texto completoBracci, Ciarapica, Zabaleta, Tartaglione, Pirozzi, Giuliani, Piva et al. "BRCA1 and BRCA2 Gene Expression: Diurnal Variability and Influence of Shift Work". Cancers 11, n.º 8 (9 de agosto de 2019): 1146. http://dx.doi.org/10.3390/cancers11081146.
Texto completoGuo, Li yuan, Tiantian Han, Didi Guo, Juan Ma, Yaping Zhao, Fanfeng Bu, Siqi Chen, Wanglong Deng y Ran Ding. "Retrospective analysis of non-BRCA gene pathogenicity variation in Chinese patients with ovarian cancer." Journal of Clinical Oncology 40, n.º 16_suppl (1 de junio de 2022): 10584. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.10584.
Texto completoDias Nunes, Joana, Isabelle Demeestere y Melody Devos. "BRCA Mutations and Fertility Preservation". International Journal of Molecular Sciences 25, n.º 1 (22 de diciembre de 2023): 204. http://dx.doi.org/10.3390/ijms25010204.
Texto completoSzentmartoni, Gyongyver, Dorottya Mühl, Renata Csanda, Attila Marcell Szasz, Zoltan Herold y Magdolna Dank. "Predictive Value and Therapeutic Significance of Somatic BRCA Mutation in Solid Tumors". Biomedicines 12, n.º 3 (6 de marzo de 2024): 593. http://dx.doi.org/10.3390/biomedicines12030593.
Texto completoBarbero, Giovanna, Roberta Zuntini, Pamela Magini, Laura Desiderio, Michela Bonaguro, Anna Myriam Perrone, Daniela Rubino et al. "Characterization of BRCA Deficiency in Ovarian Cancer". Cancers 15, n.º 5 (28 de febrero de 2023): 1530. http://dx.doi.org/10.3390/cancers15051530.
Texto completoWoodward, Emma R. y Stefan Meyer. "Fanconi Anaemia, Childhood Cancer and the BRCA Genes". Genes 12, n.º 10 (27 de septiembre de 2021): 1520. http://dx.doi.org/10.3390/genes12101520.
Texto completoOktay, Kutluk, Ja Yeon Kim, David Barad y Samir N. Babayev. "Association of BRCA1 Mutations With Occult Primary Ovarian Insufficiency: A Possible Explanation for the Link Between Infertility and Breast/Ovarian Cancer Risks". Journal of Clinical Oncology 28, n.º 2 (10 de enero de 2010): 240–44. http://dx.doi.org/10.1200/jco.2009.24.2057.
Texto completoLee, Yen-Chien, Yen-Ling Lee y Chung-Yi Li. "BRCA Genes and Related Cancers: A Meta-Analysis from Epidemiological Cohort Studies". Medicina 57, n.º 9 (30 de agosto de 2021): 905. http://dx.doi.org/10.3390/medicina57090905.
Texto completoSekine, Masayuki, Koji Nishino y Takayuki Enomoto. "Differences in Ovarian and Other Cancers Risks by Population and BRCA Mutation Location". Genes 12, n.º 7 (8 de julio de 2021): 1050. http://dx.doi.org/10.3390/genes12071050.
Texto completoSpizzo, Gilbert, Alberto Puccini, Joanne Xiu, Richard M. Goldberg, Axel Grothey, Anthony Frank Shields, Sukeshi Patel Arora et al. "Frequency of BRCA mutation in biliary tract cancer and its correlation with tumor mutational burden (TMB) and microsatellite instability (MSI)." Journal of Clinical Oncology 37, n.º 15_suppl (20 de mayo de 2019): 4085. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.4085.
Texto completoSeeber, Andreas, Alberto Puccini, Joanne Xiu, Richard M. Goldberg, Axel Grothey, Anthony Frank Shields, Mohamed E. Salem et al. "Association of BRCA-mutant pancreatic cancer with high tumor mutational burden (TMB) and higher PD-L1 expression." Journal of Clinical Oncology 37, n.º 15_suppl (20 de mayo de 2019): 4133. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.4133.
Texto completoSeeber, Andreas, Kai Zimmer, Florian Kocher, Alberto Puccini, Joanne Xiu, Chadi Nabhan, Andrew Elliott et al. "Molecular characteristics of BRCA1/2 and PALB2 mutations in pancreatic ductal adenocarcinoma". ESMO Open 5, n.º 6 (noviembre de 2020): e000942. http://dx.doi.org/10.1136/esmoopen-2020-000942.
Texto completoRichters, Lisa Katharina, Philip C. Schouten, Stefan Kommoss, Jan Hauke, Alexander Burges, Dimo Dietrich, Ahmed El-Balat et al. "BRCA-like classification in ovarian cancer: Results from the AGO-TR1-trial." Journal of Clinical Oncology 35, n.º 15_suppl (20 de mayo de 2017): 5546. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.5546.
Texto completoShweash, Muhannad, Saddam Jumaa Naseer, Maisam Khider Al-anii y Thulfiqar Fawwaz Mutar. "A MOLECULAR-BASED APPROACH TO INVESTIGATE BREAST CANCER 1 AND BREAST CANCER 2 STATUS IN OVARIAN CANCER AMONG IRAQI WOMEN". Asian Journal of Pharmaceutical and Clinical Research 11, n.º 7 (7 de julio de 2018): 199. http://dx.doi.org/10.22159/ajpcr.2018.v11i7.25217.
Texto completoHou, Minmin, Li Sun, Xiuzhang Yu, Pengyao Du, Chuang Liu, Fanfan Meng, Yaxuan Zhang y Ling Li. "The landscape of BRCA1 and BRCA2 alterations in Chinese ovarian cancer patients." Journal of Clinical Oncology 41, n.º 16_suppl (1 de junio de 2023): e17565-e17565. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.e17565.
Texto completoDe Bono, Johann S., Nobuaki Matsubara, Nicolas Penel, Niven Mehra, Michael Paul Kolinsky, Emmanuelle Bompas, Susan Feyerabend et al. "Exploratory gene-by-gene analysis of olaparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): PROfound." Journal of Clinical Oncology 39, n.º 6_suppl (20 de febrero de 2021): 126. http://dx.doi.org/10.1200/jco.2021.39.6_suppl.126.
Texto completoAtchley, Deann P., Constance T. Albarracin, Adriana Lopez, Vicente Valero, Christopher I. Amos, Ana Maria Gonzalez-Angulo, Gabriel N. Hortobagyi y Banu K. Arun. "Clinical and Pathologic Characteristics of Patients With BRCA-Positive and BRCA-Negative Breast Cancer". Journal of Clinical Oncology 26, n.º 26 (10 de septiembre de 2008): 4282–88. http://dx.doi.org/10.1200/jco.2008.16.6231.
Texto completoNovikova, EI, EA Kudinova, VK Bozhenko y VA Solodkiy. "Characteristics of BRCA-associated breast cancer in the population of the Russian Federation". Features of HIV and SARS-CoV-2 coinfection in a pandemic, n.º 2021(1) (febrero de 2021): 24–29. http://dx.doi.org/10.24075/brsmu.2021.006.
Texto completoAntunes Meireles, Pedro, Sofia Fragoso, Teresa Duarte, Sidónia Santos, Catarina Bexiga, Priscila Nejo, Ana Luís et al. "Comparing Prognosis for BRCA1, BRCA2, and Non-BRCA Breast Cancer". Cancers 15, n.º 23 (3 de diciembre de 2023): 5699. http://dx.doi.org/10.3390/cancers15235699.
Texto completoIncorvaia, Lorena, Alessia Fiorino, Anna Paola Carreca, Stefania Gori, Saverio Cinieri, Giuseppe Curigliano, Chiara Brando et al. "Heart toxicity effects (HTE) of anthracyclines-containing regimens (ACRs) in patients with breast cancer (BC) carrying mutational signature of homologous recombination deficiency (HRD)." Journal of Clinical Oncology 40, n.º 16_suppl (1 de junio de 2022): 10519. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.10519.
Texto completoAbida, Wassim, Alan Haruo Bryce, Nicholas J. Vogelzang, Robert J. Amato, Ivor John Percent, Jeremy David Shapiro, Raymond S. McDermott et al. "Genomic characteristics of deleterious BRCA1 and BRCA2 alterations and associations with baseline clinical factors in patients with metastatic castration-resistant prostate cancer (mCRPC) enrolled in TRITON2." Journal of Clinical Oncology 37, n.º 15_suppl (20 de mayo de 2019): 5031. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.5031.
Texto completoReisinger, Raquel, Sergiusz Wesolowski, Umang Swami, Pedro C. Barata, Edgar Javier Hernandez, Roberto Nussenzveig, Gordon Lemmon et al. "Differences in the genomic landscape of advanced prostate cancer (aPC) patients (pts) with BRCA1 versus BRCA2 mutations as detected by machine learning analysis of the comprehensive genomic profile (CGP) of cell-free DNA (cfDNA)." Journal of Clinical Oncology 39, n.º 6_suppl (20 de febrero de 2021): 162. http://dx.doi.org/10.1200/jco.2021.39.6_suppl.162.
Texto completoBurciaga-Flores, Carlos H., Diana C. Perez-Ibave, Maria L. Garza-Rodriguez, Oscar Vidal-Gutierrez, Cynthia M. Villarreal-Garza y Dione Aguilar y. Mendez. "Abstract 3947: Non-BRCA variants in hereditary breast and ovarian cancer patients in the Northern Mexico population". Cancer Research 84, n.º 6_Supplement (22 de marzo de 2024): 3947. http://dx.doi.org/10.1158/1538-7445.am2024-3947.
Texto completoAllain, Dawn C., Kevin Sweet y Doreen M. Agnese. "Management Options after Prophylactic Surgeries in Women with BRCA Mutations: A Review". Cancer Control 14, n.º 4 (octubre de 2007): 330–37. http://dx.doi.org/10.1177/107327480701400403.
Texto completoOshi, Masanori, Shipra Gandhi, Rongrong Wu, Mariko Asaoka, Li Yan, Akimitsu Yamada, Kazutaka Narui et al. "Establishment of a novel BRCAness score that predicts response to PARP inhibitors." Journal of Clinical Oncology 40, n.º 16_suppl (1 de junio de 2022): 549. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.549.
Texto completoTabaliuk, Y. O., L. A. Rybchenko, B. T. Klimuk y S. V. Klymenko. "Screening for mutations in BRCA1 and BRCA2 genes and related perspectives for the healthcare system". Visnik ukrains'kogo tovaristva genetikiv i selekcioneriv 18, n.º 1-2 (29 de enero de 2021): 44–57. http://dx.doi.org/10.7124/visnyk.utgis.18.1-2.1354.
Texto completoGirolimetti, Giulia, Anna Myriam Perrone, Donatella Santini, Elena Barbieri, Flora Guerra, Simona Ferrari, Claudio Zamagni, Pierandrea De Iaco, Giuseppe Gasparre y Daniela Turchetti. "BRCA-Associated Ovarian Cancer: From Molecular Genetics to Risk Management". BioMed Research International 2014 (2014): 1–11. http://dx.doi.org/10.1155/2014/787143.
Texto completoChoi, Doo Ho, Min Hyuk Lee, Allen E. Bale, Darryl Carter y Bruce G. Haffty. "Incidence of BRCA1 and BRCA2 Mutations in Young Korean Breast Cancer Patients". Journal of Clinical Oncology 22, n.º 9 (1 de mayo de 2004): 1638–45. http://dx.doi.org/10.1200/jco.2004.04.179.
Texto completoPanda, Anshuman, Mark N. Stein, Gregory Riedlinger, Gyan Bhanot y Shridar Ganesan. "Role for immune checkpoint blockade in BRCA2-mutant prostate cancer." Journal of Clinical Oncology 37, n.º 8_suppl (10 de marzo de 2019): 59. http://dx.doi.org/10.1200/jco.2019.37.8_suppl.59.
Texto completoSecondino, Angela, Flavio Starnone, Iolanda Veneruso, Maria Di Tella, Serena Conato, Carmine De Angelis, Sabino De Placido y Valeria D’Argenio. "Evaluation of a Four-Gene Panel for Hereditary Cancer Risk Assessment". Genes 13, n.º 4 (13 de abril de 2022): 682. http://dx.doi.org/10.3390/genes13040682.
Texto completoOktay, K., J. Kim, D. Barad, N. Gleicher y S. Babayev. "Association of BRCA1 mutations with diminished ovarian reserve: A common genetic mechanism for breast/ovarian cancer, and infertility?" Journal of Clinical Oncology 27, n.º 15_suppl (20 de mayo de 2009): 11039. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.11039.
Texto completoWesolowski, R., A. G. Shealy, J. Tao y H. C. Moore. "Differential outcomes in patients treated with endocrine therapy for early or locally advanced breast cancer based on BRCA mutation status". Journal of Clinical Oncology 27, n.º 15_suppl (20 de mayo de 2009): e22065-e22065. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.e22065.
Texto completoGoindani, Piryanka, Ghulam Haider, Ammara ., Faiza Mahar, Ahra Sami, Perah Manzoor y Monika Bai. "Positivity of BRCA 1 & 2 Mutations in Ovarian Cancer". Pakistan Journal of Medical and Health Sciences 17, n.º 5 (23 de mayo de 2024): 681–83. http://dx.doi.org/10.53350/pjmhs2023175681.
Texto completoTian, Jiangfang, Du He, Zhixi Huang, Bole Tian y Dan Cao. "Main driver genes and BRCA mutation in Chinese patients with pancreatic adenocarcinoma." Journal of Clinical Oncology 37, n.º 15_suppl (20 de mayo de 2019): e15741-e15741. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e15741.
Texto completoCaleca, Laura, Mara Colombo, Thomas van Overeem Hansen, Conxi Lázaro, Siranoush Manoukian, Michael T. Parsons, Amanda B. Spurdle y Paolo Radice. "GFP-Fragment Reassembly Screens for the Functional Characterization of Variants of Uncertain Significance in Protein Interaction Domains of the BRCA1 and BRCA2 Genes". Cancers 11, n.º 2 (28 de enero de 2019): 151. http://dx.doi.org/10.3390/cancers11020151.
Texto completoMadariaga, Ainhoa, Stephanie Lheureux y Amit Oza. "Tailoring Ovarian Cancer Treatment: Implications of BRCA1/2 Mutations". Cancers 11, n.º 3 (23 de marzo de 2019): 416. http://dx.doi.org/10.3390/cancers11030416.
Texto completoBayrakli, Fatih, Bekir Akgun, Burcak Soylemez, Metin Kaplan y Mustafa Gurelik. "Variation in the BRCA2 gene in a child with medulloblastoma and a family history of breast cancer". Journal of Neurosurgery: Pediatrics 8, n.º 5 (noviembre de 2011): 476–78. http://dx.doi.org/10.3171/2011.8.peds11210.
Texto completoKapoor, Nimmi S., Lisa D. Curcio, Carlee A. Blakemore, Amy K. Bremner, Rachel E. McFarland, John G. West y Kimberly C. Banks. "Benefits and safety of multigene panel testing in patients at risk for hereditary breast cancer." Journal of Clinical Oncology 33, n.º 28_suppl (1 de octubre de 2015): 16. http://dx.doi.org/10.1200/jco.2015.33.28_suppl.16.
Texto completoAbdrakhmanova, Aliya, Nazgul Omarbayeva, Dilyara Kaidarova, Gulnur Zhunussova, Saltanat Abdikerim, Saule Yessenkulova, Aizhan Jakipbayeva, Zhanna Chingissova y Leila Djansugurova. "Next generation sequencing analysis of key genes in breast cancer patients from Kazakh population." Journal of Clinical Oncology 38, n.º 15_suppl (20 de mayo de 2020): e13548-e13548. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e13548.
Texto completoWang, Xinfeng, Tomi Jun, Nan Sun, Jie He y Kuan-lin Huang. "Abstract 5692: Tissue specificity of chromosome aneuploidy correlates with BRCA-associated cancer risk". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): 5692. http://dx.doi.org/10.1158/1538-7445.am2022-5692.
Texto completo